Report Detail

According to our (Global Info Research) latest study, the global GMP Plasmid DNA Manufacturing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The growing interest and investment in gene therapy contribute to the demand for GMP plasmid DNA manufacturing. Plasmid DNA is often used as a vector in gene therapy applications.
Technological advancements in biotechnology enhance the efficiency and capabilities of plasmid DNA manufacturing processes, driving the market forward.
This report is a detailed and comprehensive analysis for global GMP Plasmid DNA Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GMP Plasmid DNA Manufacturing market size and forecasts, in consumption value ($ Million), 2021-2032
Global GMP Plasmid DNA Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global GMP Plasmid DNA Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global GMP Plasmid DNA Manufacturing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GMP Plasmid DNA Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GMP Plasmid DNA Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories, Patheon, AGC Biologics, Creative Biolabs, Synbio Technologies, Aldevron, Takara Bio, Recipharm, Eurogentec, Akron Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
GMP Plasmid DNA Manufacturing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Market segment by Application
Cancers
Inherited Disorders
Viral Infections
Other
Market segment by players, this report covers
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe GMP Plasmid DNA Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GMP Plasmid DNA Manufacturing, with revenue, gross margin, and global market share of GMP Plasmid DNA Manufacturing from 2021 to 2026.
Chapter 3, the GMP Plasmid DNA Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and GMP Plasmid DNA Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of GMP Plasmid DNA Manufacturing.
Chapter 13, to describe GMP Plasmid DNA Manufacturing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of GMP Plasmid DNA Manufacturing by Type
    • 1.3.1 Overview: Global GMP Plasmid DNA Manufacturing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global GMP Plasmid DNA Manufacturing Consumption Value Market Share by Type in 2025
    • 1.3.3 Research Grade Plasmid DNA
    • 1.3.4 Commercial Grade Plasmid DNA
  • 1.4 Global GMP Plasmid DNA Manufacturing Market by Application
    • 1.4.1 Overview: Global GMP Plasmid DNA Manufacturing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancers
    • 1.4.3 Inherited Disorders
    • 1.4.4 Viral Infections
    • 1.4.5 Other
  • 1.5 Global GMP Plasmid DNA Manufacturing Market Size & Forecast
  • 1.6 Global GMP Plasmid DNA Manufacturing Market Size and Forecast by Region
    • 1.6.1 Global GMP Plasmid DNA Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global GMP Plasmid DNA Manufacturing Market Size by Region, (2021-2032)
    • 1.6.3 North America GMP Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe GMP Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific GMP Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.6 South America GMP Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa GMP Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Charles River Laboratories
    • 2.1.1 Charles River Laboratories Details
    • 2.1.2 Charles River Laboratories Major Business
    • 2.1.3 Charles River Laboratories GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.1.4 Charles River Laboratories GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.2 Patheon
    • 2.2.1 Patheon Details
    • 2.2.2 Patheon Major Business
    • 2.2.3 Patheon GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.2.4 Patheon GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Patheon Recent Developments and Future Plans
  • 2.3 AGC Biologics
    • 2.3.1 AGC Biologics Details
    • 2.3.2 AGC Biologics Major Business
    • 2.3.3 AGC Biologics GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.3.4 AGC Biologics GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AGC Biologics Recent Developments and Future Plans
  • 2.4 Creative Biolabs
    • 2.4.1 Creative Biolabs Details
    • 2.4.2 Creative Biolabs Major Business
    • 2.4.3 Creative Biolabs GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.4.4 Creative Biolabs GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Creative Biolabs Recent Developments and Future Plans
  • 2.5 Synbio Technologies
    • 2.5.1 Synbio Technologies Details
    • 2.5.2 Synbio Technologies Major Business
    • 2.5.3 Synbio Technologies GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.5.4 Synbio Technologies GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Synbio Technologies Recent Developments and Future Plans
  • 2.6 Aldevron
    • 2.6.1 Aldevron Details
    • 2.6.2 Aldevron Major Business
    • 2.6.3 Aldevron GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.6.4 Aldevron GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Aldevron Recent Developments and Future Plans
  • 2.7 Takara Bio
    • 2.7.1 Takara Bio Details
    • 2.7.2 Takara Bio Major Business
    • 2.7.3 Takara Bio GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.7.4 Takara Bio GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Takara Bio Recent Developments and Future Plans
  • 2.8 Recipharm
    • 2.8.1 Recipharm Details
    • 2.8.2 Recipharm Major Business
    • 2.8.3 Recipharm GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.8.4 Recipharm GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Recipharm Recent Developments and Future Plans
  • 2.9 Eurogentec
    • 2.9.1 Eurogentec Details
    • 2.9.2 Eurogentec Major Business
    • 2.9.3 Eurogentec GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.9.4 Eurogentec GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Eurogentec Recent Developments and Future Plans
  • 2.10 Akron Biotech
    • 2.10.1 Akron Biotech Details
    • 2.10.2 Akron Biotech Major Business
    • 2.10.3 Akron Biotech GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.10.4 Akron Biotech GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Akron Biotech Recent Developments and Future Plans
  • 2.11 Catalent Biologics
    • 2.11.1 Catalent Biologics Details
    • 2.11.2 Catalent Biologics Major Business
    • 2.11.3 Catalent Biologics GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.11.4 Catalent Biologics GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Catalent Biologics Recent Developments and Future Plans
  • 2.12 Xpress Biologics
    • 2.12.1 Xpress Biologics Details
    • 2.12.2 Xpress Biologics Major Business
    • 2.12.3 Xpress Biologics GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.12.4 Xpress Biologics GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Xpress Biologics Recent Developments and Future Plans
  • 2.13 Esco Aster
    • 2.13.1 Esco Aster Details
    • 2.13.2 Esco Aster Major Business
    • 2.13.3 Esco Aster GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.13.4 Esco Aster GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Esco Aster Recent Developments and Future Plans
  • 2.14 Biovian
    • 2.14.1 Biovian Details
    • 2.14.2 Biovian Major Business
    • 2.14.3 Biovian GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.14.4 Biovian GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Biovian Recent Developments and Future Plans
  • 2.15 GenScript ProBio
    • 2.15.1 GenScript ProBio Details
    • 2.15.2 GenScript ProBio Major Business
    • 2.15.3 GenScript ProBio GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.15.4 GenScript ProBio GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 GenScript ProBio Recent Developments and Future Plans
  • 2.16 Andelyn Biosciences
    • 2.16.1 Andelyn Biosciences Details
    • 2.16.2 Andelyn Biosciences Major Business
    • 2.16.3 Andelyn Biosciences GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.16.4 Andelyn Biosciences GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Andelyn Biosciences Recent Developments and Future Plans
  • 2.17 WuXi Advanced Therapies
    • 2.17.1 WuXi Advanced Therapies Details
    • 2.17.2 WuXi Advanced Therapies Major Business
    • 2.17.3 WuXi Advanced Therapies GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.17.4 WuXi Advanced Therapies GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 WuXi Advanced Therapies Recent Developments and Future Plans
  • 2.18 Waisman Biomanufacturing
    • 2.18.1 Waisman Biomanufacturing Details
    • 2.18.2 Waisman Biomanufacturing Major Business
    • 2.18.3 Waisman Biomanufacturing GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.18.4 Waisman Biomanufacturing GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Waisman Biomanufacturing Recent Developments and Future Plans
  • 2.19 GenScript Biotech
    • 2.19.1 GenScript Biotech Details
    • 2.19.2 GenScript Biotech Major Business
    • 2.19.3 GenScript Biotech GMP Plasmid DNA Manufacturing Product and Solutions
    • 2.19.4 GenScript Biotech GMP Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 GenScript Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global GMP Plasmid DNA Manufacturing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of GMP Plasmid DNA Manufacturing by Company Revenue
    • 3.2.2 Top 3 GMP Plasmid DNA Manufacturing Players Market Share in 2025
    • 3.2.3 Top 6 GMP Plasmid DNA Manufacturing Players Market Share in 2025
  • 3.3 GMP Plasmid DNA Manufacturing Market: Overall Company Footprint Analysis
    • 3.3.1 GMP Plasmid DNA Manufacturing Market: Region Footprint
    • 3.3.2 GMP Plasmid DNA Manufacturing Market: Company Product Type Footprint
    • 3.3.3 GMP Plasmid DNA Manufacturing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global GMP Plasmid DNA Manufacturing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global GMP Plasmid DNA Manufacturing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global GMP Plasmid DNA Manufacturing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global GMP Plasmid DNA Manufacturing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America GMP Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 6.2 North America GMP Plasmid DNA Manufacturing Market Size by Application (2021-2032)
  • 6.3 North America GMP Plasmid DNA Manufacturing Market Size by Country
    • 6.3.1 North America GMP Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 6.3.2 United States GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe GMP Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 7.2 Europe GMP Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 7.3 Europe GMP Plasmid DNA Manufacturing Market Size by Country
    • 7.3.1 Europe GMP Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.3 France GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific GMP Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific GMP Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific GMP Plasmid DNA Manufacturing Market Size by Region
    • 8.3.1 Asia-Pacific GMP Plasmid DNA Manufacturing Consumption Value by Region (2021-2032)
    • 8.3.2 China GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.5 India GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America GMP Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 9.2 South America GMP Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 9.3 South America GMP Plasmid DNA Manufacturing Market Size by Country
    • 9.3.1 South America GMP Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa GMP Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa GMP Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa GMP Plasmid DNA Manufacturing Market Size by Country
    • 10.3.1 Middle East & Africa GMP Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE GMP Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 GMP Plasmid DNA Manufacturing Market Drivers
  • 11.2 GMP Plasmid DNA Manufacturing Market Restraints
  • 11.3 GMP Plasmid DNA Manufacturing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 GMP Plasmid DNA Manufacturing Industry Chain
  • 12.2 GMP Plasmid DNA Manufacturing Upstream Analysis
  • 12.3 GMP Plasmid DNA Manufacturing Midstream Analysis
  • 12.4 GMP Plasmid DNA Manufacturing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on GMP Plasmid DNA Manufacturing. Industry analysis & Market Report on GMP Plasmid DNA Manufacturing is a syndicated market report, published as Global GMP Plasmid DNA Manufacturing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of GMP Plasmid DNA Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report